Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 784, pseudogene (RN7SL784P)** is a human pseudogene located in the genome but does not encode a functional protein and is not known to be transcribed to a functional RNA[1][3][6][8]. Pseudogenes like RN7SL784P are typically “genomic fossils” derived from once-functional genes, in this case, related to the 7SL RNA that forms the RNA component of the signal recognition particle (SRP) complex[7][9]. The SRP is essential for directing newly synthesized proteins to the endoplasmic reticulum, but RN7SL784P itself does not encode a functional SRP RNA, nor is it considered a therapeutic target, receptor, enzyme, or known disease-causing factor[1][6][8][9]. Current literature does not ascribe a functional, diagnostic, or therapeutic role to RN7SL784P; it represents a family of “processed pseudogenes”—truncated, noncoding DNA sequences that arose from reverse transcription of ancestral 7SL RNA genes and subsequent genomic insertion. Most 7SL pseudogenes, including RN7SL784P, are not expressed and are not implicated in human pathology or therapy[1][3][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 784, pseudogene (RN7SL784P).